logo
B12 Supplements and IVs Promise an Energy Boost. Here's What the Science Says

B12 Supplements and IVs Promise an Energy Boost. Here's What the Science Says

Yahoo21-07-2025
B12, a vitamin naturally found in animal products, has become the internet's favorite solution to low energy, fatigue, and overall sluggishness. It's long made an appearance in multivitamins and standalone pills—but these days, its footprint seems to be ballooning. Energy drinks and shots are juiced up with the ingredient, as are IV drips promising things like vitality and hangover relief. And of course, a growing market of run-of-the-mill B12 tablets and gummies tout similar claims, suggesting the vitamin can give you an instant energy lift. But as with most supplements, marketing can be deceiving, and the truth about B12 isn't quite so 'easy pick-me-up' as you might (desperately) want to believe.
B12 is indeed a critical vitamin to consume. It plays a key role in forming red blood cells (which shuttle oxygen to your organs) and helps convert food into energy, so it makes sense why people might associate it with getting a boost, Gary Soffer, MD, director of the Integrative Medicine Program at Yale School of Medicine, tells SELF. It also helps create new DNA molecules (which are necessary to repair cells and form new ones) and maintain healthy nerves (hence why B12 deficiency is linked with neuropathy and even cognitive decline). Plus, the body can't make it, so we have to get it from outside sources, like meat, fish, eggs, and dairy items.
But at the same time, we don't need much B12 to reap its benefits—the recommended amount for adults is 2.4 micrograms daily, which most people in the US typically hit with food. So, are there benefits to taking a supplemental form of it? And how can you tell if you might actually be B12 deficient? Read on for everything you need to know about taking B12 and when, if ever, it may be something your doctor recommends.
Spoiler alert: There's no evidence that suggests loading up on B12 will give you energy if you're not deficient.
It's true that a lack of vitamin B12 in your system—less than around 150 picograms per milliliter of blood—could manifest as fatigue or weakness. (Though it's worth noting, B12 deficiency doesn't always trigger symptoms.) Without enough B12, you could wind up with larger-than-usual red blood cells that don't effectively transport oxygen to your organs, which is a form of anemia. Plus, low B12 levels could interfere with your body's typical process for churning out energy from food, which may contribute to lethargy. And it can eventually diminish the protective covering on your nerves, leading to neurological symptoms like numbness and tingling in your hands and feet, and mood changes. So if your doctor determines that you have a B12 deficiency, taking a B12 supplement could restore your energy and resolve other related symptoms. However, as few as 6% of people in the US under age 60 have a B12 deficiency.
If you're like the majority of the population that is not substantially missing out on B12, consuming more than the recommended daily value isn't going to make any difference—no matter how fatigued you may be. After all, there are a bunch of non-B12-related causes for tiredness, ranging from stress, dehydration, and poor sleep habits to medical conditions like depression and hypothyroidism. 'It's the same reason why taking more iron when you're not iron-deficient isn't going to increase your energy, either,' Elisabeth Fowlie Mock, MD, MPH, a family physician in Bangor, Maine, and a member of the board of directors of the American Academy of Family Physicians, tells SELF. Not to mention, your body will just flush out any extra B12 in your pee. 'It works like a gas tank,' Dr. Soffer explains, 'so if you take more [than it needs], it'll just spill over.'
Any boost you might feel from popping a B12 supplement is generally a placebo. When it comes to shots and energy drinks laden with the stuff, there's a greater chance that you're feeling buzzy in response to other ingredients like caffeine and sugar. And the instant refreshment of an IV drip is often tied simply to the rush of hydration.
B12 deficiency is pretty rare, though a few GI disorders could make it more likely.
Most people in the US get plenty of B12 via their diet. (A single serving of beef or Greek yogurt, or two large eggs can get you about halfway to the recommended daily value, and one serving of salmon or canned tuna is enough to surpass it.) So doctors don't generally suspect a B12 deficiency (at least, not off the bat) if someone comes to them with malaise or fatigue, Dr. Mock says, nor do they routinely check B12 levels with a blood test. That said, your doctor may be suspicious of deficiency if you report not only tiredness but also the neurological or cognitive symptoms noted above. Same goes if you're experiencing other symptoms of anemia like shortness of breath, dizziness, pale skin, and a fast heartbeat. Iron deficiency is a more likely culprit there, Dr. Mock says, but your doctor may still check your B12 level to be safe.
The other scenario that may prompt them to assess B12 for low energy is if you have a risk factor for deficiency. A big one is being vegetarian or vegan. After all, B12 only occurs naturally in animal products. While there are veg-friendly foods that are fortified with B12, like some cereals, plant milks, and nutritional yeast, it's still easier to fall short if you're in this camp, Dr. Soffer notes.
Because of the way B12 is absorbed via stomach acids, deficiency is also more common in those who have GI-related conditions. In particular, people who take common heartburn meds called proton pump inhibitors (that reduce stomach acid production) may be at higher risk, as are older adults, who just tend to have less stomach acid. (The number of people with B12 deficiency jumps from 6% to nearly 20% for the 60-plus population.)
All types of B12, whether in animal sources or fortified foods, also need to sync up in the stomach with a protein called intrinsic factor in order to be fully absorbed. And some people might not make enough of this protein for that process to work. This can happen to those with a condition called pernicious anemia, as well as folks with certain GI disorders (like celiac or Crohn's) or alcohol use disorder (AUD), and those who've had bariatric surgery or another procedure that involved removing some or all of their stomach. So if you fall in one of these groups, there's reason to suspect you might be dealing with a bonafide B12 deficiency. (But if that's you, there's also a good chance you're already aware of your potential for nutrient deficiencies, Dr. Mock points out, and feeling fatigued will be far from your only symptom.)
If you *do* have a B12 deficiency, a supplement isn't always the solution.
In the particular cases above where a B12 deficiency could be on the table, your doctor may first run some routine bloodwork. This includes a measure of the average size of your red blood cells called mean corpuscular volume (MCV). A high MCV could prompt them to check your B12 level with an additional blood test, Dr. Mock says. (A normal MCV, by contrast, is reassurance that B12 probably isn't the issue, she adds.)
If your B12 is indeed below the norm, it's important to work with your doctor to figure out how to raise your level. You might be able to do this via food, perhaps by eating more B12-fortified items. Experts agree, it's best to consume any vitamins and minerals via food because your body can use them more easily than in supplement form. Not to mention, the supplement industry is a hazy, unregulated one. These OTC products don't have to go through the same rigorous FDA approval process as medications, so it can be tough to know if you're getting what's on the label. That said, if your doctor does suggest taking an oral supplement to close the gap, they can steer you toward a reputable brand that's been third-party tested. They can also advise on the ideal dose and format (pill or under-the-tongue lozenge), and whether it makes sense for you to take a B-complex product (including a mix of B vitamins) or a standalone B12 supplement.
Worth noting: In cases of deficiency caused by a GI or health condition that hinders absorption, just downing more B12 in supplement form might not solve the problem. After all, B12 in pills (or souped-up energy drinks) still needs to connect with intrinsic factor in the gut to get absorbed. That's why, in these specific situations, your doctor might recommend supplementing B12 via prescription injections or nasal gels, which bypass the GI route completely and go straight into your bloodstream.
Bottom line: Most people with fatigue aren't lacking B12, so supplements aren't the solution.
Low B12 is an uncommon reason for feeling tired. Chances are, if you have a deficiency, it coincides with one of the specific lifestyle or health-related situations above. 'Someone who has no known risk factors who truly has a vitamin B12 deficiency is a needle in a haystack,' Dr. Mock says. For most people, taking in extra B12 will just give you B12-rich pee…rather than any noticeable boost.
So, what to do if you're feeling sapped and craving energy? Dr. Mock recommends turning to some tried-and-true lifestyle changes, like cutting down on screen time, getting outside in nature more often, fitting in daily movement (at least a few hours before bedtime), and eating a balanced diet that includes breakfast. These tips may not be as sexy as the latest B12-infused drip, drink, or pill, but they're bound to help you get better sleep at night and feel more rested and ready-to-go come daytime. If you try out a few of these and still can't seem to escape the drag of constant fatigue? It's worth seeing your doctor. Low B12 may not be the root cause—but they can certainly help you figure out if a medical condition might be lurking, and what you can do to get the pep back in your step.
Related:
3 Things to Do When You're So, So Tired But Sleeping More Isn't an Option
How to Feel Less Depleted by the End of the Workweek
6 Less Obvious Signs of Burnout You Should Definitely Pay Attention To
Get more of SELF's great service journalism delivered right to your inbox.
Originally Appeared on Self
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

Yahoo

time3 hours ago

  • Yahoo

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@

Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US

Yahoo

time3 hours ago

  • Yahoo

Sarepta shares rebound after shipments of gene therapy Elevidys resume in US

(Reuters) -Sarepta Therapeutics shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and decreases the risk of market withdrawal. The company said on Monday it would resume shipments of Elevidys — approved in the U.S. to treat a rare condition called Duchenne muscular dystrophy — to patients who can walk. U.S. shipments to patients who cannot walk independently are still halted, following the death of two teenage boys earlier this year. These incidents brought heightened regulatory scrutiny to Sarepta in recent weeks, while the pause of shipments raised concerns about the future of Elevidys — the company's largest revenue generator. Sarepta's announcement followed the U.S. Food and Drug Administration's recommendation that the voluntary hold on shipments be removed after a probe showed the death of an 8-year-old boy in Brazil was not related to Elevidys. Wall Street analysts said the resumption of shipments would allow Sarepta to fulfill its near-term payments to partner Arrowhead and maintain access to its debt facilities. "The FDA's recommendation and the resumption of commercial treatment in the U.S. virtually eliminate the risk of Elevidys being formally withdrawn from the market," said William Blair analyst Sami Corwin. While the decision allows some patients to regain access to the treatment, analysts warned that patients and doctors could show hesitancy in light of the recent hit to reputation. "It remains to be seen how the news headlines regarding the patient deaths will affect commercial interest in the near term," Corwin said. Sarepta's partner Roche had also stopped Elevidys shipments in certain countries outside the U.S. Shares of Sarepta surged 36% to $18.85 in premarket trading. They have fallen more than 80% since the first Elevidys-related death was reported in March. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

What Is Superintelligence? Everything You Need to Know About AI's Endgame
What Is Superintelligence? Everything You Need to Know About AI's Endgame

CNET

time3 hours ago

  • CNET

What Is Superintelligence? Everything You Need to Know About AI's Endgame

You've probably chatted with ChatGPT, experimented with Gemini, Claude or Perplexity, or even asked Grok to verify a post on X. These tools are impressive, but they're just the tip of the artificial intelligence iceberg. Lurking beneath is something far bigger that has been all the talk in recent weeks: artificial superintelligence. Some people use the term "superintelligence" interchangeably with artificial general intelligence or sci-fi-level sentience. Others, like Meta CEO Mark Zuckerberg, use it to signal their next big moonshot. ASI has a more specific meaning in AI circles. It refers to an intelligence that doesn't just answer questions but could outthink humans in every field: medicine, physics, strategy, creativity, reasoning, emotional intelligence and more. We're not there yet, but the race has already started. In July, Zuckerberg said during an interview with The Information that his company is chasing "personal superintelligence" to "put the power of AI directly into individuals' hands." Or, in Meta's case, probably in everyone's smart glasses. Scott Stein/CNET That desire kicked off a recruiting spree for top researchers in Silicon Valley and a reshuffling inside Meta's FAIR team (now Meta AI) to push Meta closer to AGI and eventually ASI. So, what exactly is superintelligence, how close are we to it, and should we be excited or terrified? Let's break it down. What is superintelligence? Superintelligence doesn't have a formal definition, but it's generally described as a hypothetical AI system that would outperform humans at every cognitive task. It could process vast amounts of data instantly, reason across domains, learn from mistakes, self-improve, develop new scientific theories, write flawless code, and maybe even make emotional or ethical judgments. The idea became popularized through philosopher Nick Bostrom's 2014 book Superintelligence: Paths, Dangers, Strategies , which warned of a scenario where an AI bot becomes smarter than humans, self-improves rapidly and then escapes our control. That vision sparked both excitement and fear among tech experts. Speaking to CNET, Bostrom says many of his 2014 warnings "have proven quite prescient." What has surprised him, he says, is "how anthropomorphic current AI systems are," with large language models behaving in surprisingly humanlike ways. Bostrom says he's now shifting his attention toward deeper issues, including "the moral status of digital minds and the relationship between the superintelligence we build with other superintelligences," which he refers to as "the cosmic host." For some, ASI represents the pinnacle of progress, a tool to cure disease, reverse climate change and crack the secrets of the universe. For others, it's a ticking time bomb -- one wrong move and we're outmatched by a machine we can't control. It's sometimes called the last human invention, not because it's final, but because ASI could invent everything else we need. British mathematician Irving John Good described it as an "intelligence explosion." Superintelligence doesn't exist yet. We're still in the early stages of what's called artificial narrow intelligence. It's an AI system that is great at specific tasks like translation, summarization and image generation, but not capable of broader reasoning. Tools like ChatGPT, Gemini, Copilot, Claude and Grok fall into this category. They're good at some tasks, but still flawed, prone to hallucinations and incapable of true reasoning or understanding. To reach ASI, AI needs to first pass through another stage: artificial general intelligence. What is AGI? AGI, or artificial general intelligence, refers to a system that can learn and reason across a wide range of tasks, not just one domain. It could match human-level versatility, such as learning new skills, adapting to unfamiliar problems and transferring knowledge across fields. Unlike current chatbots, which rely heavily on training data and struggle outside of predefined rules, AGI would handle complex problems flexibly. It wouldn't just answer questions about math and history; it could invent new solutions, explain them and apply them elsewhere. Current models hint at AGI traits, like multimodal systems that handle text, images and video. But true AGI requires breakthroughs in continual learning (updating knowledge without forgetting old stuff) and real-world grounding (understanding context beyond data). And none of the major models today qualify as true AGI, though many AI labs, including OpenAI, Google DeepMind and Meta, list it as their long-term target. Once AGI arrives and self-improves, ASI could follow quickly as a system smarter than any human in every area. How close are we to superintelligence? A superintelligent future concept I generated using Grok AI. Grok / Screenshot by CNET That depends on who you ask. A 2024 survey of 2,778 AI researchers paints a sobering picture. The aggregate forecasts give a 50% chance of machines outperforming humans in every possible task by 2047. That's 13 years sooner than a 2022 poll predicted. There's a 10% chance this could happen as early as 2027, according to the survey. For job automation specifically, researchers estimate a 10% chance that all human occupations become fully automatable by 2037, reaching 50% probability by 2116. Most concerning, 38% to 51% of experts assign at least a 10% risk of advanced AI causing human extinction. Geoffrey Hinton, often called the Godfather of AI, warned in a recent YouTube podcast that if superintelligent AI ever turned against us, it might unleash a biological threat like a custom virus -- super contagious, deadly and slow to show symptoms -- without risking itself. Resistance would be pointless, he said, because "there's no way we're going to prevent it from getting rid of us if it wants to." Instead, he argued that the focus should be on building safeguards early. "What you have to do is prevent it ever wanting to," he said in the podcast. He said this could be done by pouring resources into AI that stays friendly. Still, Hinton confessed he's struggling with the implications: "I haven't come to terms with what the development of superintelligence could do to my children's future. I just don't like to think about what could happen." Factors like faster computing, quantum AI and self-improving models could accelerate things. Hinton expects superintelligence in 10 to 20 years. Zuckerberg said during that podcast that he believes ASI could arrive within the next two to three years, and OpenAI CEO Sam Altman estimates it'll be somewhere in between those time frames. Most researchers agree we're still missing key ingredients, like more advanced learning algorithms, better hardware and the ability to generalize knowledge like a human brain. IBM points to areas like neuromorphic computing (hardware inspired by human neurons), evolutionary algorithms and multisensory AI as building blocks that might get us there. Meta's quest for 'personal superintelligence' Meta launched its Superintelligence Labs in June, led by Alexandr Wang (ex-Scale AI CEO) and Nat Friedman (ex-GitHub CEO), with $14.3 billion invested in Scale AI and $64 billion to $72 billion for data centers and AI infrastructure. Zuckerberg doesn't shy away from Greek mythology, with names like Prometheus and Hyperion for his two AI data superclusters (massive computing centers). He also doesn't talk about artificial superintelligence in abstract terms. Instead, he claims that Meta's specific focus is on delivering "personal super intelligence to everyone in the world." This vision, according to Zuckerberg, sets Meta apart from other research labs that he says primarily concentrate on "automating economically productive work." Bostrom thinks this isn't mere hype. "It's possible we're only a small number of years away from this," he said of Meta's plans, noting that today's frontier labs "are quite serious about aiming for superintelligence, so it is not just marketing moves." Though still in its early stages, Meta is actively recruiting top talent from companies like OpenAI and Google. Zuckerberg explained in his interview with The Information that the market is extremely competitive because so few people possess the requisite high level of skills. Facebook and Zuckerberg didn't respond to requests for comment. Should humans subscribe to the idea of superintelligent AI? There are two camps in the AI world: those who are overly enthusiastic, inflating its benefits and seemingly ignoring its downsides; and the doomers who believe AI will inevitably take over and end humanity. The truth probably lands somewhere in the middle. Widespread public fear and resistance, fueled by dystopian sci-fi and very real concerns over job loss and massive economic disruption, could slow progress toward superintelligence. One of the biggest problems is that we don't really know what even AGI looks like in machines, much less ASI. Is it the ability to reason across domains? Hold long conversations? Form intentions? Build theories? None of the current models, including Meta's Llama 4 and Grok 4, can reliably do any of this. There's also no agreement on what counts as "smarter than humans." Does it mean acing every test, inventing new math and physics theorems or solving climate change? And even if we get there -- should we? Building systems vastly more intelligent than us could pose serious risks, especially if they act unpredictably or pursue goals misaligned with ours. Without strict control, it could manipulate systems or even act autonomously in ways we don't fully understand. Brendan Englot, director of the Stevens Institute for Artificial Intelligence, shared with CNET that he believes "an important first step is to approach cyber-physical security similarly to how we would prepare for malicious human-engineered threats, except with the expectation that they can be generated and launched with much greater ease and frequency than ever before." That said, Englot isn't convinced that current AI can truly outpace human understanding. "AI is limited to acting within the boundaries of our existing knowledge base," Englot tells CNET. "It is unclear when and how that will change." Regulations like the EU AI Act aim to help, but global alignment is tricky. For example, China's approach differs wildly from the West's. Trust is one of the biggest open questions. A superintelligent system might be incredibly useful, but also nearly impossible to audit or constrain. And when AI systems draw from biased or chaotic data like real-time social media, those problems compound. Some researchers believe that given enough data, computing power and clever model design, we'll eventually reach AGI and ASI. Others argue that current AI approaches (especially LLMs) are fundamentally limited and won't scale to true general or superhuman intelligence because the human brain has 100 trillion connections. That's not even accounting for our capability of emotional experience and depth, arguably humanity's strongest and most distinctive attribute. But progress moves fast, and it would be naive to dismiss ASI as impossible. If it does arrive, it could reshape science, economics and politics -- or threaten them all. Until then, general intelligence remains the milestone to watch. If and when superintelligence does become a reality, it could profoundly redefine human life itself. According to Bostrom, we'd enter what he calls a "post-instrumental condition," fundamentally rethinking what it means to be human. Still, he's ultimately optimistic about what lies on the other side, exploring these ideas further in his most recent book, Deep Utopia. "It will be a profound transformation," Bostrom tells CNET.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store